AP707, Placebo clinical trials

A phase II, double-blinded, placebo-controlled, clinical trial to determine the efficacy and safety of AP707 in the treatment of Borderline Personality Disorder.

This study is testing a new medication called AP707 for people with Borderline Personality Disorder. Researchers want to see if AP707 helps improve symptoms and if it's safe to use, compared to a dummy pill (placebo).